Hebei Tangzhi Technology Co., Ltd.
Manufacturing high-quality solid dosage forms often presents a complex set of challenges. Production managers and formulators frequently struggle with inconsistent powder flow rates, poor compressibility, and fluctuating disintegration times. When your formulation relies on precision, compromising on excipient quality leads to costly production bottlenecks and rejected batches. Addressing these exact obstacles requires a superior grade binder and diluent—specifically, high-performance Microcrystalline Cellulose PH101 NF.
Hebei Tangzhi Technology Co., Ltd., founded in 2010, has engineered its operations to eliminate these industry pain points. By providing tailor-made solutions and continuous innovation, we transform manufacturing liabilities into operational strengths. Our state-of-the-art facilities guarantee a massive daily production capacity of over 110 tons, ensuring that supply chain interruptions are a thing of the past.
Authority in Execution: Operating under a rigorous Quality System Management Certificate, our products are trusted globally and currently exported to over 30 countries. With an active international presence—including major exhibitions in Pakistan and Indonesia—and over 12 years of deep industry expertise, we deliver unparalleled batch-to-batch consistency.
Achieving structural integrity in wet granulation and direct compression processes is not an accident; it is a matter of strict adherence to technical specifications. The physiochemical properties of your excipients directly dictate the mechanical strength and dissolution profile of the final product. We mandate rigorous analytical testing to ensure our Microcrystalline Cellulose PH101 NF exceeds baseline regulatory expectations.
Below is a detailed breakdown of the critical parameters we monitor, demonstrating how our internal engineering benchmarks translate directly into competitive manufacturing advantages for our global partners.
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Particle Size (D50) | Determines powder flowability and uniform blending capabilities. | ~50 µm | Ensures excellent wet granulation and precise die-filling without segregation. |
| Loss on Drying (LOD) | Moisture impacts Active Pharmaceutical Ingredient (API) degradation and tablet capping. | < 5.0% | Maximizes shelf-life and stability for highly moisture-sensitive formulations. |
| Bulk Density | Directly affects hopper flow, compression force required, and final weight consistency. | 0.26 - 0.31 g/cc | Provides robust structural integrity and lowers the risk of weight variation. |
| Purity & Compliance | Critical for regulatory approvals and international pharmacopeial standards. | 100% NF / USP Compliant | Zero regulatory friction, enabling seamless entry into 30+ export markets. |
Long-term financial performance in manufacturing is driven by yield optimization and raw material reliability. Procuring substandard excipients frequently results in hidden costs: increased machine wear, higher defect rates, and delayed time-to-market. By integrating our premium Microcrystalline Cellulose PH101 NF into your supply chain, you are making a strategic investment in process efficiency.
With our robust infrastructure—backed by a dedicated Ministry of Foreign Trade established in March 2022—we offer dynamic scaling to meet your project demands. The consistent quality of our cellulose derivatives drastically reduces formulation waste and minimizes equipment downtime, translating technical superiority directly into measurable Return on Investment (ROI).
Related products
Top Selling Products
